About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT

NCT01552655·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Odense University Hospital

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Clinical suspected recurrence of breast cancer
Blood glucose level less than 8,0 mmol/L

You may not be if

Disqualified patients
Other malignancies
\< 18 years
\< 50 kg
\> 90 kg
Pregnant or lactating
Patients with permanent address outside of the Region of Southern Denmark
Estimated inability to collaborate

The record

StatusCompleted

PhaseNo phase

Taking part101

StartedDec 2011

UpdatedApr 21, 2015

Conditions

Breast Cancer Recurrent

Where1

Department of Nuclear Medicine, Odense University Hospital
Odense, Funen, Denmark

Clareo Health | Breast Cancer Recurrence - the Accuracy of Dual-time PET/CT